Samit Hirawat - EVP,Chief Med.Offr.,Drug Dev. at BRISTOL MYERS SQUIBB CO

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP,Chief Med.Offr.,Drug Dev.
Issuer Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
All Insider Reports
All Insider Reports

Samit Hirawat - trading volume in the past year for BRISTOL MYERS SQUIBB CO

Holdings reported by Samit Hirawat for BRISTOL MYERS SQUIBB CO

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 83,513 $3,973,571 $47.58 25 Apr 2025 Direct
Market Share Units 35,146 $1,862,387 $52.99 10 Mar 2025 Direct Common Stock, $0.10 par value
Performance Shares 52,720 10 Mar 2025 Direct Common Stock, $0.10 par value

Transactions reported by Samit Hirawat for BRISTOL MYERS SQUIBB CO

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.